Document Detail


Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
MedLine Citation:
PMID:  7499009     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Data on the efficacy and safety of pentavalent antimony in the treatment of visceral leishmaniasis during pregnancy are scanty. A case of visceral leishmaniasis in a 39-year-old woman in the second trimester of pregnancy is reported here. The patient was hospitalized in poor condition with high fever and pancytopenia which had lasted for 6 weeks. A bone marrow aspirate revealed numerous amastigotes and serodiagnosis for Leishmania was positive at a high titer. The patient was successfully treated with meglumine antimoniate at a daily dose of 850 mg of antimony for 20 days. She delivered at term a healthy female baby who remains in good condition at 18 months of age. Thus a dose of 850 mg of antimony, which is lower than that presently recommended, seems to be effective and non toxic to the fetus when administered at the second trimester of pregnancy.
Authors:
R Utili; A Rambaldi; M F Tripodi; A Andreana
Related Documents :
3515349 - Effects of gonadotropin-releasing hormone treatment on ovarian steroid production durin...
9805359 - A light and ultrastructural study of rice bodies recovered from a case of date thorn-in...
1990189 - Maternal outcome after open fetal surgery. a review of the first 17 human cases.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Infection     Volume:  23     ISSN:  0300-8126     ISO Abbreviation:  Infection     Publication Date:    1995 May-Jun
Date Detail:
Created Date:  1996-01-18     Completed Date:  1996-01-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0365307     Medline TA:  Infection     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  182-3     Citation Subset:  IM    
Affiliation:
Institute of Medical Therapy, Faculty of Medicine, 2nd University of Naples, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Animals
Antiprotozoal Agents / therapeutic use*
Bone Marrow / parasitology
Female
Humans
Infant, Newborn
Leishmania infantum / isolation & purification
Leishmaniasis, Visceral / drug therapy*
Meglumine / therapeutic use*
Organometallic Compounds / therapeutic use*
Pregnancy
Pregnancy Complications, Parasitic / drug therapy*
Pregnancy Trimester, Second
Chemical
Reg. No./Substance:
0/Antiprotozoal Agents; 0/Organometallic Compounds; 133-51-7/meglumine antimoniate; 6284-40-8/Meglumine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acute suppurative thyroiditis caused by Salmonella enteritidis.
Next Document:  Uncomplicated central vein catheterization of high risk patients with real time ultrasound guidance.